查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2023-2030 年全球呼吸分析儀和藥物檢測設備市場
市場調查報告書
商品編碼
1176572

2023-2030 年全球呼吸分析儀和藥物檢測設備市場

Global Breathalyzer and Drug Testing Equipment Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概覽

在預測期內（2023 年至 2030 年），呼吸分析儀和藥物檢測設備市場規模預計將以 16.8% 的複合年增長率增長。

酒精測試設備可為警察、工業和個人用途提供快速、可靠且衛生的預測試。 呼吸分析儀還具有數據存儲功能，可快速訪問過去的測試結果。 酒精測試使用診斷設備來估計一個人的血液酒精濃度 (BAC)。 通過向設備呼氣，一個人可以確定他們是否超過了駕駛的法定限制。 需要血液、唾液、尿液或呼吸樣本來確定一個人體內的酒精或乙醇含量。

市場動態

全球呼吸分析儀和藥物檢測設備市場受到技術進步的推動。 呼氣分析儀和藥物檢測設備的日益普及、酒後駕車和吸毒成癮事件的增加以及嚴格的政府法規和法律旨在減少在藥物和酒精的影響下駕駛時發生的事故，推動了市場的發展。我來了。

在藥物和酒精影響下發生的駕駛事故增加促進了市場增長

減少在藥物和酒精影響下駕駛時發生事故的嚴格政府法規和法律將在預測期內推動市場發展。 根據世界衛生組織 2022 年報告，道路交通傷害是一個重大的公共衛生問題，也是全球死亡和受傷的主要原因。 每年約有 130 萬人死於道路交通事故，數百萬人受傷或致殘，其中大部分發生在低收入和中等收入國家。 道路交通傷害不僅給個人、家庭和社區帶來巨大的社會成本，而且給衛生服務和經濟帶來沉重負擔。

酒精在許多社會中都具有文化和社會作用。 然而，我們在日常生活中的許多情況下都會經歷酒精的有害影響。 大量文獻表明，酒後駕車會顯著增加事故的風險和嚴重程度，導致死亡和重傷。

世界衛生組織在其最新報告中估計，全世界 5% 至 35% 的道路死亡與酒精有關。 在大多數高收入國家，約 20% 的死亡驅動因素是血液酒精濃度超過法定限值。 低收入和中等收入國家的研究發現，33% 和 69% 的死亡事故司機以及 8% 和 29% 的非死亡事故司機在事故發生前飲酒。 在藥物和酒精的影響下事故的增加以及政府法規的收緊正在推動全球市場。

一些呼吸分析儀給出不准確和錯誤的結果，阻礙了市場增長

但是，某些呼吸分析儀存在校準不當、化學溶液不當、改裝不當、編程不當、方法不當、電子乾擾、某些健康狀況以及接觸化學品等問題。有些可能會給出不准確和錯誤的結果，例如接觸到 這些因素阻礙了市場的增長。

COVID-19 影響分析

COVID-19 的出現對全球呼吸分析儀和藥物測試設備市場產生了積極影響。 根據 2021 年發表在《災難醫學與公共衛生防備》上的一篇文章，2019 年冠狀病毒病大流行提供了一種準確、快速、簡便的方法來應對社區爆發和評估疾病的傳播。需要一種診斷工具可以管理。 呼吸分析技術中包含的人工智能已被證明具有通過分析呼吸中的揮發性有機化合物來診斷癌症和肺部疾病等各種疾病的潛力。 因此，我們認為它適用於在大規模公共衛生行動中診斷 COVID-19，因為它快速、易於使用且無創。

2022 年 4 月，美國食品和藥物管理局發布了第一個 COVID-19 診斷測試的緊急使用授權，以檢測呼吸樣本中與 SARS-CoV-2 感染相關的化學物質。 可以在收集和測試患者標本的環境（例如診所、醫院和移動測試站點）中使用隨身攜帶包大小的設備進行測試。

使用氣相色譜-質譜 (GC-MS) 分析 COVID-19，以分離和鑑定呼出氣中與 SARS-CoV-2 感染相關的化學物質和五種揮發性有機化合物的混合物。(VOC)，InspectIR COVID-19 呼氣測醉器檢測 SARS-CoV-2 的 VOC 標記物，產生假設的（未經證實的）陽性測試結果，需要通過分子測試進行確認。

內容

第 1 章市場研究方法和範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

第四章市場動態

  • 市場影響因素
    • 司機
      • 事故數量增加
      • 增加教育活動
    • 約束因素
      • 診斷不准確
    • 商機
    • 影響分析

第五章行業分析

  • 波特的五力分析
  • 供應鏈分析
  • 監管分析

第 6 章 COVID-19 分析

  • COVID-19 市場分析
    • COVID-19 之前的市場情景
    • COVID-19 的當前市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 總結

第 7 章按產品類型

  • 氧化物半導體呼氣分析儀
  • 燃料電池呼氣分析儀
  • 分光光度呼吸分析儀

第八章應用

  • 酒精檢測
  • 藥物檢測
  • 支氣管哮喘檢測
  • 結核病測試
  • 法醫檢查
  • 其他

第 9 章最終用戶

  • 聯邦機構
  • 醫院
  • 康復中心
  • 私人公司
  • 其他

第10章按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第11章競爭格局

  • 主要發展和戰略
  • 公司股票分析
  • 按類型劃分的基準

第12章公司簡介

  • C4 Development
    • 公司概況
    • 產品組合和說明
    • 主要亮點
    • 財務摘要
  • Cannabix Technologies Inc.
  • Intoxalock
  • Hound Labs
  • BACtrack
  • Lion Laboratories Limited
  • Intoximeters, Inc.
  • Lifeloc Technologies, Inc.
  • Lifesafer
  • Ekips Technologies

第13章 DataM

簡介目錄
Product Code: DMCD1129

Market Overview

Breathalyzer And Drug Testing Equipment Market size was valued at US$ YY million in 2022 and is estimated to reach US$ YY million by 2030, growing at a CAGR of 16.8% during the forecast period (2023-2030).

Alcohol screening devices perform pretests in police, industrial and personal applications fast, reliable and hygienically. The breathalyzers also provide data storage for quick access to past test results. A breathalyzer test uses a diagnostic device to estimate a person's blood alcohol content (BAC). By blowing into the device, a person can determine whether they are over the legal limit to drive. Measuring the amount of alcohol, or ethanol, in a person's system requires a blood, saliva, urine, or breath sample.

Market Dynamics

Technological advancements drive the global breathalyzer and drug testing equipment market. The growing adoption of breathalyzers and drug testing equipment, the increasing number of drunk and drive cases and drug addiction and stringent government regulations and laws to reduce driving incidences under the influence of drugs and alcohol boosts the market.

Rising driving incidences under the influence of drugs and alcohol drives market growth

The stringent government regulations and laws to reduce driving incidences under the influence of drugs and alcohol drive the market in the forecast period. As per the World Health Organization Report 2022, road traffic injuries are a major public health problem and a foremost cause of death and injury worldwide. Every year around 1.3 million people die, and millions more are injured or disabled due to road crashes, mostly in low- and middle-income countries. As well as creating enormous social costs for individuals, families and communities, road traffic injuries heavily burden health services and economies.

Alcohol plays a cultural and social role in many societies. However, the harmful effects of alcohol experienced in many aspects of daily life are undeniable. An extensive body of literature identifies that driving after drinking alcohol significantly raises the risk of a crash and the severity of that crash, resulting in deaths and serious injuries.

In its latest reports, the WHO estimates that between 5% and 35% of global road deaths are alcohol-related. In most high-income countries, about 20% of fatally injured drivers have blood alcohol concentration levels above the legal limit. Studies in low- and middle-income countries have shown that 33% and 69% of fatally injured drivers and 8% and 29% of non-fatally injured drivers had consumed alcohol before their crashes. The rising incidences under the influence of drugs and alcohol and rising government regulations drive the market worldwide.

The inaccurate and wrong results provided by some breathalyzers will hamper the growth of the market

However, inaccurate and wrong results are provided by some breathalyzers due to improper calibration, incorrect chemical solutions, inappropriate modifications, faulty programming, improper methodology, electronic interference, certain health conditions, and exposure to chemicals. These factors are hampering the market growth.

COVID-19 Impact Analysis

The appearance of COVID-19 positively impacted the global breathalyzer and drug testing equipment market. According to the article published in Disaster Medicine and Public Health Preparedness in 2021, due to the coronavirus disease 2019 pandemic, there is a demand for accurate, rapid, and easy-to-administer diagnostic tools to support communities address local outbreaks and assess the spread of disease. Artificial intelligence within breath analysis techniques has been shown to potentially diagnose various diseases, such as cancer and lung disease, by analyzing volatile organic compounds in exhaled breath. This, combined with their rapid, easy-to-use, and noninvasive nature, makes them a suitable candidate for use in diagnosing COVID-19 in large-scale public health operations.

In April 2022, the U.S. Food and Drug Administration issued an emergency use authorization for the first COVID-19 diagnostic test that detects chemical compounds in breath samples related to a SARS-CoV-2 infection. The test can be conducted in environments where the patient specimen is collected and examined, such as doctor's offices, hospitals and mobile testing sites, utilizing an instrument about the carry-on luggage size.

The InspectIR COVID-19 Breathalyzer employs gas chromatography gas mass-spectrometry (GC-MS) to isolate and identify chemical mixtures and quickly detect five Volatile Organic Compounds (VOC) associated with SARS-CoV-2 infection in an exhaled breath when the InspectIR COVID-19 Breathalyzer detects VOC markers of SARS-CoV-2, a hypothetical (unconfirmed) positive test result is produced and should be confirmed with a molecular test.

Segment Analysis

The alcohol detection segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The alcohol detection segment accounts for the largest market share. Imagine the loss of lives caused due to people driving under the influence of alcohol. Through our alcohol detection device, police officers can instantly figure out people driving under the influence of alcohol and stop them, reducing drunk driving scenarios.

Manufacturers are providing the products in the market. For instance, Lifeloc Technologies, Inc. is a trusted U.S. manufacturer of precise, reliable And easy-to-use portable breath alcohol testing instruments (breathalyzers). Lifeloc's L Series of portable breath alcohol testers or "breathalyzers" are state-of-the-art and the most powerful, simple to use and advanced product on the market.

Also, in October 2022, Cannabix Technologies Inc., developer of breath testing devices for law enforcement and the workplace, reported that the Company had created a cutting-edge Contactless Alcohol Breathalyzer for workplaces and vehicles. Cannabix engineers have developed a suite of Contactless Alcohol Breathalyzer (CAB) offerings, including wall-mounted and in-vehicle (behind the steering column) versions.

Geographical Analysis

North America region holds the largest market share of the global Breathalyzer and Drug Testing Equipment market

North America dominates the breathalyzer and drug testing equipment market and is anticipated to show a parallel trend over the forecast period. An increasing number of accidents and awareness programs in the North American region drive the market.

According to the WHO report 2022, consuming alcohol can be an enjoyable activity for some people. However, many people may not realize the impact on body and can impair the ability to perform routine tasks. Drinking and driving is a dangerous combination. Evidence notes that in the U.S., it is responsible for roughly 28 deaths a day, costing the U.S. approximately $44 billion annually.

In the U.S., half a million people are injured and 17,000 killed every year in drunk driving-related traffic crashes. Almost 40% of all youth road fatalities are directly related to alcohol consumption.

Using breathalyzers can help reduce the number of motor vehicle accidents involving an alcohol-impaired driver. This device estimates the concentration of alcohol in the breath to decide whether a person has drunk too much alcohol to drive safely. All these factors are driving the market in the North American region.

Competitive Landscape

The breathalyzer and drug testing equipment market are a moderately competitive presence of local and global companies. Some of the key players contributing to the market's growth are C4 Development, Cannabix Technologies Inc., Intoxalock, Hound Labs, BACtrack, Lion Laboratories Limited, Intoximeters, Inc., Lifeloc Technologies, Inc., Lifesafer, and Ekips Technologies, among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, contributing to the growth of the breathalyzer and drug testing equipment market globally.

For instance,

In October 2022, Cannabix Technologies Inc., developer of marijuana breathalyzer devices for law enforcement and the workplace, reports it will be partaking in a mid-October study date to test a supplemental version of its FAIMS technology for the detection of Delta 9-tetrahydrocannabinol and related analytes in human breath in a complete multi-analysis study of subjects under the effect of marijuana in the southern United States.

C4 Development

Overview:

C4 Development provides the most advanced tailor-made alcohol tester and ITS products to different countries. Alcovisor, a series of alcohol breath analyzers created and manufactured by the company. Alcovisor provides drivers with a testing machine to measure their alcohol degree before driving.

Product Portfolio:

JupiterX: This is android 5.1, built-in printer, GPS, 4G/WIFI Photo Capture, provide evidential records by auto-capturing while subject blowing, 100,000 test data stored in memory, 4.3" color touch screen. The mouthpiece can be automatically ejected, and a USB PC connection.

The global breathalyzer and drug testing equipment market report would provide access to approximately 55+ market data tables, 55+ figures, and in the range of 200 (approximate) pages.

Table of Contents

1. Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing number of accidents
      • 4.1.1.2. Increase in the number of awareness programs
    • 4.1.2. Restraints:
      • 4.1.2.1. Inaccurate diagnosis
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Semiconductor Oxide Breathalyzers*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Fuel Cell Breathalyzers
  • 7.4. Spectrophotometer Breathalyzers

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Alcohol Detection*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Drug Detection
  • 8.4. Asthma Detection
  • 8.5. Tuberculosis Detection
  • 8.6. Forensic Test
  • 8.7. Others

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Federal Departments*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Hospitals
  • 9.4. Rehabilitation Centers
  • 9.5. Private Sectors
  • 9.6. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Key Developments and Strategies
  • 11.2. Company Share Analysis
  • 11.3. Type Benchmarking

12. Company Profiles

  • 12.1. C4 Development*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Cannabix Technologies Inc.
  • 12.3. Intoxalock
  • 12.4. Hound Labs
  • 12.5. BACtrack
  • 12.6. Lion Laboratories Limited
  • 12.7. Intoximeters, Inc.
  • 12.8. Lifeloc Technologies, Inc.
  • 12.9. Lifesafer
  • 12.10. Ekips Technologies

LIST NOT EXHAUSTIVE

13. Global Breathalyzer and Drug Testing Equipment Market - DataM

  • 13.1. Appendix
  • 13.2. About Us and Services
  • 13.3. Contact Us